Bon Natural Life (BON)
NASDAQ:BON
BON Stock Chart & Stats
$1.70
-$0.04(-2.34%)
At close: 4:00 PM EST
$1.70
-$0.04(-2.34%)
Day’s Range― - ―
52-Week Range$1.13 - $3.40
Previous Close$1.67
Volume111.86K
Average Volume (3M)2.24M
Market Cap
$10.49M
Enterprise Value$13.91M
Total Cash (Recent Filing)$6.27M
Total Debt (Recent Filing)$12.32M
Price to Earnings (P/E)―
Beta1.81
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding6,086,971
10 Day Avg. Volume115,576
30 Day Avg. Volume2,242,045
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.09
Price to Sales (P/S)0.29
P/FCF Ratio-1.27
Enterprise Value/Market Cap1.33
Enterprise Value/Revenue0.74
Enterprise Value/Gross Profit3.59
Enterprise Value/Ebitda634.36
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Balance-sheet BufferThe company’s equity base has expanded materially (≈$57.6M in 2025) while leverage remains modest (debt-to-equity ~0.21). That equity cushion improves solvency and provides room to fund R&D or absorb short-term losses without immediate refinancing pressure, supporting multi-month resilience.
AI-driven Biomanufacturing PartnershipThe joint lab and three-year cooperation with Chang’an Pilot formalize a structural shift to AI-enhanced biomanufacturing. This can sustainably raise production efficiency, improve input consistency, and lower unit costs over time, strengthening competitive position in natural ingredient supply chains.
Strengthened Technical LeadershipHiring a CTO with deep academic credentials in chemical engineering and supramolecular chemistry signals a durable emphasis on R&D capability. Over months this can translate into higher-quality product pipelines, better process scale-up and stronger IP or technical differentiation in ingredient extraction and biosynthesis.
Bears Say
Persistent Negative Free Cash FlowOngoing negative free cash flow and nearly zero operating cash in 2025 indicate structural cash burn. Over a multi-month horizon this forces reliance on external financing or balance-sheet drawdown, reducing optionality for strategic investments and increasing refinancing and liquidity risk if losses persist.
Revenue And Margin DeteriorationMaterial revenue decline and sustained margin compression that produced a net loss suggest weakening pricing power or rising costs. If demand or cost structure does not reverse, profitability recovery will be difficult, undermining long-term cash generation and the business model’s scalability.
Rising Debt And Negative ReturnsDebt has increased materially year-over-year while ROE turned negative, indicating the company is adding leverage as profitability deteriorates. This combination reduces financial flexibility and raises the probability that future borrowing costs or covenant pressure will constrain operational choices over several months.
Bon Natural Life News
BON FAQ
What was Bon Natural Life’s price range in the past 12 months?
Bon Natural Life lowest stock price was $1.13 and its highest was $3.40 in the past 12 months.
What is Bon Natural Life’s market cap?
Bon Natural Life’s market cap is $10.49M.
When is Bon Natural Life’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Bon Natural Life’s earnings last quarter?
Currently, no data Available
Is Bon Natural Life overvalued?
According to Wall Street analysts Bon Natural Life’s price is currently Overvalued.
Does Bon Natural Life pay dividends?
Bon Natural Life does not currently pay dividends.
What is Bon Natural Life’s EPS estimate?
Bon Natural Life’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Bon Natural Life have?
Bon Natural Life has 6,086,971 shares outstanding.
What happened to Bon Natural Life’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Bon Natural Life?
Currently, no hedge funds are holding shares in BON
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Bon Natural Life
Bon Natural Life Limited, together with its subsidiaries, engages in the research and development, manufacture, and sale of functional active ingredients extracted from natural herb plants in the People's Republic of China and internationally. The company provides personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers; natural health supplements comprising powder drinks and bioactive food ingredient products primarily used as food additives; and nutritional supplements. Its products are principally used by manufacturer customers in the functional food, personal care, cosmetic, and pharmaceutical industries. The company was founded in 2006 and is headquartered in Grand Cayman, the Cayman Islands.
Technical Analysis
Planet Green Holdings
―
Natural Alternatives International
―
Farmmi
―
Laird Superfood
―
Healthy Choice Wellness Corp. Class A
―